• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168

(3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride: A Comprehensive Overview

The compound with CAS No. 1187932-68-8, commonly referred to as (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride, has garnered significant attention in the fields of organic chemistry and pharmacology. This compound is a derivative of pyridine, a six-membered aromatic ring with one nitrogen atom, and is characterized by the presence of a trifluoromethyl group at the 3-position and a methylamine substituent at the 2-position. The hydrochloride salt form further enhances its stability and solubility, making it a valuable compound for various applications.

Recent studies have highlighted the potential of (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride in drug discovery and development. Its unique structure, which combines electron-withdrawing groups (the trifluoromethyl group) and electron-donating groups (the methylamine group), provides a platform for modulating pharmacokinetic properties such as absorption, distribution, metabolism, and excretion (ADME). This makes it an attractive candidate for designing bioactive molecules with improved therapeutic indices.

The synthesis of (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride involves a multi-step process that typically begins with the preparation of the pyridine ring. The introduction of the trifluoromethyl group at the 3-position is often achieved through electrophilic substitution reactions, while the methylamine group is introduced at the 2-position via nucleophilic substitution or coupling reactions. The final step involves protonation of the amine group to form the hydrochloride salt, ensuring optimal solubility and stability for downstream applications.

One of the most promising applications of this compound lies in its role as an intermediate in medicinal chemistry. Researchers have explored its use in constructing complex heterocyclic frameworks, which are essential components of many bioactive molecules. For instance, recent studies have demonstrated its utility in synthesizing novel kinase inhibitors and G-protein coupled receptor (GPCR) modulators. These findings underscore its potential in addressing unmet medical needs across various therapeutic areas, including oncology, neuroscience, and cardiovascular diseases.

In addition to its role as an intermediate, (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride has also been investigated for its direct biological activity. Preclinical studies have shown that it exhibits moderate inhibitory activity against certain enzymes implicated in inflammatory diseases. Furthermore, its ability to modulate ion channels has opened new avenues for exploring its potential in treating neurological disorders such as epilepsy and chronic pain.

The structural versatility of this compound has also made it a valuable tool in chemical biology. Its use as a building block in click chemistry reactions has enabled researchers to rapidly assemble complex molecules with high precision. This approach has significantly accelerated drug discovery efforts by reducing the time and resources required for synthesizing potential lead compounds.

From an environmental standpoint, (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride exhibits favorable biodegradation properties, making it less likely to persist in ecosystems. This aligns with current trends toward sustainable chemistry practices that minimize environmental impact while maintaining high standards of safety and efficacy.

In conclusion, (3-Trifluoromethyl-pyridin-2-yl)methylamine hydrochloride represents a versatile and promising compound with wide-ranging applications in organic synthesis and drug development. Its unique structure, combined with recent advancements in synthetic methodologies and biological applications, positions it as a key player in advancing modern medicinal chemistry. As research continues to uncover new insights into its properties and potential uses, this compound is poised to make significant contributions to the field of pharmaceutical sciences.

• 1250443-60-7((3-(Trifluoromethyl)pyridin-2-yl)methanamine dihydrochloride)
• 1582801-09-9(methyl({3-(trifluoromethyl)pyridin-2-ylmethyl})amine)
• 1315613-18-3([3-(difluoromethyl)pyridin-2-yl]methanamine)
• 1805226-35-0(2-(Aminomethyl)-5-(difluoromethyl)-3-(trifluoromethyl)pyridine)
• 1805317-67-2(2-(Aminomethyl)-6-(difluoromethyl)-3-(trifluoromethyl)pyridine)
• 871826-12-9([5-(trifluoromethyl)pyridin-2-yl]methanamine hydrochloride)
• 886371-24-0(3-(Trifluoromethyl)-2-pyridinemethanamine)
• 1805330-99-7(2-(Aminomethyl)-3-(difluoromethyl)-4-methylpyridine)
• 1951441-74-9(N-Methyl-1-(3-(trifluoromethyl)pyridin-2-yl)methanamine hydrochloride)
• 1350637-24-9((5-(Trifluoromethyl)pyridin-2-yl)methanamine dihydrochloride)